Recent trends in the recreational use of pharmaceuticals among young adults in the United States highlight a number of issues regarding the problematization of drugs. Two constructions of recreational pharmaceutical use are analyzed. On the one hand, categorical frameworks based upon epidemiological data are created by institutions and media and depict recreational pharmaceutical use as illicit in unqualified, absolute terms. This is done through discourses that equate nonmedical pharmaceutical use with culturally established forms of illicit drug use. On the other hand, users' multi-dimensional constructions of recreational pharmaceutical use emphasize social context, personal experience, and individual risk perceptions. The problematization of recreational pharmaceutical use points to intergenerational conflicts, as well as to struggles over definitions of “drug abuse” and “hard drugs,” and highlights the impact of pharmaceuticalization on recreational drug use among young people.
AbrahamJ. (2011). Sociology of pharmaceuticals development and regulation: A realist empirical research programme. In WilliamsS.J.GabeJ. and DavisP. (Eds.), Pharmaceuticals and society: Critical discourses and debates (pp. 54–70). West Sussex, UK: Wiley-Blackwell.
2.
AckerC. J. (2002). Creating the American junkie: Addiction research in the classic era of narcotic control. Baltimore, MD: Johns Hopkins University Press.
3.
AkersR.L. (1991). Addiction: The troublesome concept. Journal of Drug Issues, 21(4), 777–793.
4.
AgarM. (1985). Folks and professionals: Different models for the interpretation of drug use. The International Journal of the Addictions, 20(1), 173–182.
5.
Anderson-FyeE. P., & FloerschJ. (2011). “I'm not your typical ‘homework stresses me out’ kind of girl”: Psychological anthropology in research on college student usage of psychiatric medications and mental health services. Ethos, 39(4), 501–521 [doi:10.1111/j.1548-1352.2011.01209.x].
BardhiF.SifaneckS. J.JohnsonB. D., & DunlapE. (2007). Pills, thrills and bellyaches: Case studies of prescription pill use and misuse among marijuana/blunt smoking middle class young women. Contemporary Drug Problems, 34(1), 53–101.
8.
BernardH. R. (2011). Research Methods in Anthropology. Lanham, MD: Rowman Altamira.
9.
BlancoC.OkudaM.WrightD.HasinD.S.GrantB.F.LiuS. (2008). Mental health of college students and their non-college attending peers: Results from the National Epidemiologic Study on alcohol related conditions. Archives of General Psychiatry, 65(12), 1429–1437.
10.
BoeriM. (2004). “Hell, I'm an addict, but I ain't no junkie”: An ethnographic analysis of aging heroin users. Human Organization, 63(2), 236–245.
11.
BourgoisP. (2000). Disciplining addictions: The bio-politics of methadone and heroin in the United States. Culture, Medicine and Psychiatry, 24(2), 165–195 [doi 10.1023/A:1005574918294].
BoysA.MarsdenJ., & StrangJ. (2001). Understanding reasons for drug use amongst young people: A functional perspective. Health Education Research, 16(4), 457–469 [doi:10.1093/her/16.4.457].
14.
BukoskiW. J. (1991). A framework for drug abuse prevention research. In LeukefeldC.G. & BukowskiW.J. (Eds.) Drug abuse prevention intervention research: Methodological issues (pp. 7–28) [NIDA Research Monograph 107]. Rockville, MD: National Institute on Drug Abuse.
15.
BurtC.W. (2002). National trends in use of medications in office-based practice, 1985–1999. Health Affairs, 21(4), 206–214.
16.
ButlerS.F.BudmanS.H.FernandezK., & JamisonR.N. (2004). Validation of a screener and opioid assessment measure for patients with chronic pain. Pain, 112(1–2), 65–75 [doi:10.1016/j.pain.2004.07.026].
17.
CarterG.C., & WinsemanJ.S. (2003). Increasing numbers of students arrive on college campuses on psychiatric medications. Journal of College Student Psychotherapy, 18(1), 3–10.
18.
Center on Addiction and Substance Abuse. (2004). “You've got drugs!”: Prescription drug users on the internet. New York: Columbia University.
19.
Center on Addiction and Substance Abuse. (2005). Under the counter: The diversion and abuse of controlled prescription drugs in the U.S.New York: Columbia University.
20.
ColliverJ.D.KroutilL.A.DaiL., & GfoererJ.C. (2006). Misuse of prescription drugs: Data from the 2002, 2003, and 2004 national surveys on drug use and health [DHHS Publication No. SMA 06–4192]. Rockville, MD: Substance Abuse and Mental Health Services Administration, Office of Applied Studies.
21.
ComerJ.S.MojtabaiR., & MarkR. (2011). National trends in the antipsychotic treatment of psychiatric outpatients with anxiety disorders. The American Journal of Psychiatry, 168(10), 1057–1065.
22.
ConradP., & PotterD. (2000). From hyperactive children to ADHD adults: Observations on the expansion on medical categories. Social Problems, 47(4), 559–582.
23.
ConradP., & SchneiderJ.W. (1992). Deviance and medicalization: From badness to sickness. Philadelphia: Temple University Press.
24.
CourtwrightD. (1982). Dark paradise: Opiate addiction in America before 1940. Cambridge, MA: Harvard University Press.
25.
DeSantisA.D., & HaneA.C. (2010). “Adderall is definitely not a drug”: Justifications for the illegal use of ADHD stimulants. Substance Use & Misuse, 45(1–2), 31–46.
26.
Drug Abuse Warning Network. (2006). Emergency department visits involving nonmedical use of selected pharmaceuticals. Washington, DC: Substance Abuse and Mental Health Services Administration.
27.
DuffC. (2004). Drug use as a “practice of the self”: Is there any place for an “ethics of moderation” in contemporary drug policy?International Journal of Drug Policy, 15(5–6), 385–393.
28.
ElliottC. (2004). Introduction: Prozac as a way of life. In ElliotC. & ChambersT. (Eds.), Prozac as a way of life (pp. 1–18). Chapel Hill, NC: The University of North Carolina Press.
29.
FoxN. J., & WardK.J. (2009). Pharma in the bedroom … and the kitchen. … The pharmaceuticalisation of daily life. Sociology of Health & Illness, 30(6), 856–868.
30.
FrommM.G. (2007). The escalating use of medications by college students: What are they telling us, what are we telling them?Journal of College Student Psychotherapy, 21(3–4), 27–44.
31.
GoodeE., & Ben-YehudaN. (1994). Moral panics: Culture, politics, and social construction. Annual Review of Sociology, 20, 149–171.
32.
GrahamN.A.PollesA., & GoldM.S. (2006). Performance enhancing, non-prescription use of erectile dysfunction medications. Journal of Addictive Diseases, 25(Suppl. 1), 61–68.
33.
GrauL.E.DasguptaN., & Phinney-HarveyA. (2007) Illicit use of opioids: Is OxyContin® a “gateway drug”?The American Journal on Addictions, 16(3), 166–173.
34.
GreelyH.SahakianB.HarrisJ.KesslerR.C.GazzanigaM.CampbellP. (2008). Towards responsible use of cognitive-enhancing drugs by the healthy. Nature, 456, 702–705 [doi:10.1038/456702a].
35.
GreenR., & MooreD. (2009). “Kiddie drugs” and controlled pleasure: Recreational use of dexamphetamine in a social network of young Australians. International Journal of Drug Policy, 20(5), 402–408.
36.
GrinspoonL. (2000). Whither medical marijuana?Contemporary Drug Problems, 27(1), 3–15.
37.
HallS.S. (2003). The quest for a smart pill. Scientific American, 289(3), 54–65.
HarrisJ. (2007). Enhancing evolution: The ethical case for making better people. Princeton, N.J.: Princeton University Press.
40.
HorwitzA.V., & WakefieldJ.C. (2007). The loss of sadness: How psychiatry transformed normal sorrow into depressive disorder. New York: Oxford University Press.
41.
HuntG.P.EvansK., & KaresF. (2007). Drug use and meanings of risk and pleasure. Journal of Youth Studies, 10(1), 73–96 [doi:10.1080/13676260600983668].
42.
InciardiJ.A., & GoodeJ.L. (2007). OxyContin: Miracle medicine or problem drug? In InciardiJ. A. & McElrathK. (Eds.), The American drug scene: An anthology (4th ed., pp. 163–173). Los Angeles: Roxbury.
43.
JohnstonL.D.O'MalleyP.M.BachmanJ.G., and SchulenbergJ.E. (2011). Monitoring the future national results on adolescent drug use: Overview of key findings, 2010. Ann Arbor, MI: Institute for Social Research, The University of Michigan.
KeaneH. (2008). Pleasure and discipline in the uses of Ritalin. International Journal of Drug Policy, 19(5), 401–409 [doi:10.1016/j.drugpo.2007.08.002].
46.
KellyB.C. (2005). Conceptions of risk in the lives of club drug-using youth. Substance Use & Misuse, 40(9–10), 1443–1459.
47.
KellyP. (2003). Growing up as risky business? Risks, surveillance and the institutionalized mistrust of youth. Journal of Youth Studies, 6(2), 165–180.
48.
KirmayerL., & RaikhelE. (2009). From Amrita to Substance D: Pharmacology, political economy and technologies of the self. Transcultural Psychiatry, 46(1), 5–15.
49.
KlermanG.L. (1972). Psychotropic hedonism vs. pharmacological Calvinism. Hastings Center Report, 2(4), 1–3.
50.
KramerP. (1993). Listening to Prozac. New York: Penguin Books.
LeeJ., & AntinT.M.J. (2011). How do researchers categorize drugs, and how do drug users categorize them?Contemporary Drug Problems, 38(3), 387–428.
53.
LeFeverG. B.DawsonK. V., & MorrowA. L. (1999). The extent of drug therapy for attention deficit-hyperactivity disorder among children in public schools. American Journal of Public Health, 89(9), 1359–1364.
MartensM. P.PageJ. C., & MowryE. S. (2006). Differences between actual and perceived student norms: An examination of alcohol use, drug use, and sexual behavior. Journal of American College Health, 54(5), 295–300.
57.
MartinE. (2006). The pharmaceutical person. Biosocieties, 1(3), 273–287.
58.
MayockP. (2005). ‘Scripting’ risk: Young people and the construction of drug journeys. Drugs: Education, prevention and policy, 12(6), 349–368.
59.
McCabeS.E.CranfordJ.A.BoydC.J., & TeterC.J. (2007). Motives, diversion and routes of administration associated with nonmedical use of prescription opioids. Addictive Behaviors, 32(3), 562–575 [doi:10.1016/j.addbeh.2006.05.022].
60.
McCabeS.E.KnightJ.R.TeterC.J., & WechslerJ. (2005). Nonmedical use of prescription stimulants among US college students: Prevalence and correlates from a national survey. Addiction, 100(1), 96–106.
61.
McCabeS.E.TeterC.J., & BoydC. J. (2006). Medical use, illicit use, and diversion of abusable prescription drugs. Journal of American College Health, 54(5), 269–278.
62.
McCarthyM. (2007). Prescription drug abuse up sharply in the USA. The Lancet, 369(9572), 1505–1506.
63.
McKinneyK.A., & GreenfieldB. G. (2010). Self-compliance at “Prozac campus.”Anthropology & Medicine, 17(2), 173–185.
64.
MilesM.B., & HubermanA.M. (1994). Qualitative data analysis: An expanded sourcebook (2nd ed.). Thousand Oaks, CA: Sage Publications.
65.
MooreD. (2008). Erasing pleasure from public discourse on illicit drugs: On the creation and reproduction of an absence. International Journal of Drug Policy, 19(5), 353–358.
66.
MoynihanR. (2006). Selling sickness: How the world's biggest pharmaceutical companies are turning us all into patients (1st ed.). New York: Nation Books.
67.
National Institute on Drug Abuse (2001). Prescription drugs: Abuse and addiction [Publication No, 01–4881]. Bethesda, MD: National Institutes of Health.
NichterM. (2000). Fat talk: What girls and their parents say about dieting. Cambridge, MA: Harvard University Press.
70.
NovakS.P.KroutilL. A.WilliamsR. L., & BruntD.L. (2007). The nonmedical use of prescription ADHD medications: Results from a national internet panel. Substance Abuse Treatment, Prevention and Policy, 2(32). Retrieved April 13, 2012, from http://www.substance-abusepolicy.com/content/2/1/32
71.
NuttD.J.KingL.A., & PhillipsL. D. (2010). Drug harms in the UK: A multicriteria decision analysis. The Lancet, 376, 1558–1565.
OlfsonM.BlancoC.LiuL.MorenoC., & LajeG. (2006). National trends in the outpatient treatment of children and adolescents with antipsychotic drugs. Archives of General Psychiatry, 63(6), 679–685 [doi:10.1001/archpsyc.63.6.679].
75.
OrcuttJ.D., & TurnerJ.B. (1993). Shocking numbers and graphic accounts: Quantified images of drug problems in the print media. Social Problems, 40(2), 190–206.
PeeleS. (1985). The meaning of addiction: Compulsive experience and its interpretation. Lexington, MA: Lexington Books.
78.
PincusH.A.TanielianT.L.MarcusS.C.OlfsonM.ZarinD.A.ThompsonJ. (1996). Prescribing trends in psychotropic medications: Primary care, psychiatry, and other medical specialties. Journal of the American Medical Association, 279(7), 526–531.
79.
Qualitative Solutions in Research. (2002). NVivo (Version 9) [Computer software]. Bundoora, Victoria, Australia. Available from http://www.qsrinternational.com.
80.
QuinteroG. (2009). Rx for a party: Recreational pharmaceutical use in a collegiate setting. Journal of American College Health, 58(1), 64–70.
81.
QuinteroG. & BundyH. (2011). “Most of the time you already know”: Pharmaceutical information assembly by young adults on the internet. Substance Use and Misuse, 46(7), 898–909.
82.
QuinteroG.PetersonJ., & YoungB. (2006). An exploratory study of socio-cultural factors contributing to prescription drug misuse among college students. Journal of Drug Issues, 36(4), 903–931.
83.
RadcliffeP., & StevensA. (2008). Are drug treatment services only for “thieving junkie scumbags”? Drug users and the management of stigmatised identities. Social Science & Medicine, 67(7), 1065–1073.
84.
ReisJ., & RileyW. (2000). Predictors of college students' alcohol consumption: Implications for student education. The Journal of Genetic Psychology, 161(3), 282–291.
85.
RingoldD.J. (2002). Boomerang effects in response to public health interventions: Some unintended consequences in the alcoholic beverage market. Journal of Consumer Policy, 25, 27–63.
86.
RobisonL.M.SclarD.A.SkaerT.I., & GalinR.S. (1999). National trends in the prevalence of attention-deficit/hyperactivity disorder and the prescribing of methylphenidate among school-age children: 1990–1995. Clinical Pediatrics, 38(4), 209–217.
87.
RødnerS. (2005). “I am not a drug abuser, I am a drug user”: A discourse analysis of 44 drug users' construction of identity. Addiction Research and Theory, 13(4), 333–346.
RosenbaumM. (1998). “Just say know” to teenagers and marijuana. Journal of Psychoactive Drugs, 30, 197–203.
90.
RushtonJ.L., & WhitmereJ.T. (2001). Pediatric stimulant and selective serotonin reuptake inhibitor prescription trends: 1992 to 1998. Archives of Pediatric and Adolescent Medicine, 155(5), 560–565.
91.
SaferD.J.ZitoJ.M., & FineE.M. (1996). Increased methylphenidate usage for attention deficit disorder in the 1990s. Pediatrics, 98(6), 1084–1088.
92.
ShafferH.J. (1991). Toward an epistemology of “addictive disease.”Behavioral Sciences & the Law, 9(3), 269–286.
93.
ShafferH.J. (1997). The most important unresolved issue in the addictions: Conceptual chaos. Substance Use & Misuse, 32(11), 1573–1580.
94.
ShewanD.DalgarnoP., & ReithG. (2000). Perceived risk and risk reduction among ecstasy users: The role of drug, set, and setting. International Journal of Drug Policy, 10(), 431–453.
95.
SperryL., & ProsenH. (1998). Contemporary ethical dilemmas in psychotherapy: Cosmetic psychopharmacology and managed care. American Journal of Psychotherapy, 52(1), 54–63.
96.
SpringhallJ. (1999). Youth, popular culture and moral panics: Penny gaffs to gangsta rap, 1830–1996. New York: Palgrave Macmillan.
97.
StaffordR.S. (2008). Regulating off-label drug use—rethinking the role of the FDA. New England Journal of Medicine, 358(14), 1427–1429.
98.
Statistical Package for the Social Sciences. (2000). SPSS Base 11.5. Chicago, IL: SPSS, Inc.
99.
SteinH.F. (1990). In what systems do alcohol/chemical addictions make sense? Clinical ideologies and practices as cultural metaphors. Social Science & Medicine, 30(9), 987–1000.
100.
StrombergP.NichterM., & NichterM. (2007). Taking play seriously: Low-level smoking among college students. Culture, Medicine and Psychiatry, 31(1), 1–24.
101.
Substance Abuse and Mental Health Services Administration. (2008). Results from the 2007 National Survey on Drug Use and Health: National Findings [NSDUH Series H-34, DHHS Publication No. SMA 08–4343]. Rockville, MD: Author.
102.
SzaszT.S. (2003). Ceremonial chemistry: The ritual persecution of drugs, addicts, and pushers (Rev. ed.). Syracuse, NY: Syracuse University Press.
103.
TalbotM. (2009, April 27). Brain gain: The underground world of “neuroenhancment” drugs. The New Yorker, 32–43.
104.
TimimiS. (2004). A critique of the international consensus statement on ADHD. Clinical Child and Family Psychology Review, 7(1), 59–63.
105.
WebsterL.R., & WebsterR.M. (2005). Predicting aberrant behaviors in opioid-treated patients: Preliminary validation of the opioid risk tool. Pain Medicine, 6(6), 432–442.
106.
WechslerH.NelsonT.F.LeeJ.E.SeibringM., & KeelingC. (2003). Perception and reality: A national evaluation of social norms marketing interventions to reduce college students' heavy alcohol use. Journal of Studies on Alcohol, 64(4), 484–494.
107.
WellerS.C. (1998). Structured interviewing and questionnaire construction. In BernardH.R., (Ed.), Handbook of methods in cultural anthropology, (pp. 365–410). Walnut Creek, CA: Alta Mira.
108.
WellerS.C., & RomneyA.K. (1988). Systematic Data Collection. Newbury Park, CA: Sage Publications.
109.
WhaleyM., & MerittG. (2005, February 27). “Pharmers” market thriving on state's campuses; Abuse of prescription drugs becoming a huge but undocumented problem. Denver Post, p. A1.
110.
WilensT.E.AdlerL. A.AdamsJ.SgambatiS.RotrosenJ.SawtelleR. (2008). Misuse and diversion of stimulants prescribed for ADHD: A systematic review of the literature. Journal of the American Academy of Child and Adolescent Psychiatry, 47(1), 21–31.
111.
WilfordB.B.FinchJ.CzechowiczD.J., & WarrenD. (1994). An overview of prescription drug misuse and abuse: Defining the problem and seeking solutions. The Journal of Law, Medicine and Ethics, 223, 197–203.
112.
WilliamsS. J.SealeC.BodenS.LoweP., & SteinbergD.L. (2008). Waking up to sleepiness: Modafinil, the media and the pharmaceuticalization of everyday/night life. Sociology of Health and Illness, 30(6), 839–855.
113.
WilliamsS.J.GabeJ., & DavisP., (2011). The sociology of pharmaceuticals: Progress and prospects. In WilliamsS.J.GabeJ., & DavisP. (Eds.), Pharmaceuticals and society: Critical discourses and debates (pp. 1–11). West Sussex, UK: Wiley-Blackwell.
114.
Wolf-MeyerM. (2009). Precipitating pharmakologies and capital entrapments: Narcolepsy and the strange cases of Provigil and Xyrem. Medical Anthropology, 28(1), 11–30.
115.
YoungJ.R. (2003). Prozac campus: More students seek counseling and take psychiatric medications. The Chronicle of Higher Education, February 14, 37–38.
116.
ZitoJ.M.SaferD.J.DosReisS.GardnerJ.F.MagderL.SoekenK. (2003). Psychotropic practice patterns for youth: A 10-year perspective. Archives of Pediatrics and Adolescent Medicine, 157(1), 17–25.
